Genital Herpes Market: Steady Growth Outlook Through 2030

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Projected Increase In Market Value Of The Genital Herpes Market During 2026–2030?

The market size for genital herpes has experienced robust growth in recent years. This market is projected to expand from $2.34 billion in 2025 to $2.49 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.8%. Historically, this expansion can be linked to the high prevalence of HSV infections, the accessibility of antiviral drugs, public health screening initiatives, sexual health education programs, and established clinical diagnosis protocols.

The genital herpes market is projected to experience substantial growth in the coming years, with its size anticipated to reach $3.15 billion by 2030, driven by a compound annual growth rate (CAGR) of 6.0%. This projected expansion during the forecast period is primarily fueled by factors such as the ongoing development of preventive vaccines, the wider availability of rapid diagnostics, improved patient adherence to therapies, the advent of digital sexual health services, and enhanced access to healthcare. Concurrently, major trends expected within this period include an increasing adoption of antiviral suppressive therapy, heightened awareness leading to earlier diagnosis of STIs, a growing demand for point-of-care diagnostic tests, the expansion of preventive sexual health programs, and a greater focus on long-term symptom management.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/genital-herpes-global-market-report

What Major Factors Are Driving The Genital Herpes Market Forward?

An increasing emphasis on sexual well-being is projected to fuel the expansion of the genital herpes market in the future. This heightened focus on sexual health arises from a growing acknowledgement of its crucial contribution to overall well-being and life quality. Sexual health services for genital herpes principally encompass diagnosis, therapeutic interventions, advisory support, and continuous management. These services aim to assist individuals with controlling outbreaks, averting transmission, and handling the emotional and relational issues linked to the condition. For instance, the Centers for Disease Control and Prevention, a US-based government public health agency, reported in September 2025 that over 2.2 million cases of chlamydia, gonorrhea, and syphilis were documented in 2024. Consequently, this intensified attention on sexual health is anticipated to stimulate the development of the genital herpes market.

Which Segment Categories Are Included In The Genital Herpes Market Segment Analysis?

The genital herpes market covered in this report is segmented –

1) By Type: Diagnosis, Treatment

2) By Route Of Administration: Oral, Injectable, Topical

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channel

Subsegments:

1) By Diagnosis: Polymerase Chain Reaction (PCR) Tests, Viral Culture Tests, Blood Antibody Tests (Serology), Antigen Detection Tests, Point-Of-Care Rapid Tests

2) By Treatment: Antiviral Medications, Acyclovir, Valacyclovir, Famciclovir, Topical Treatments, Acyclovir Cream, Docosanol Cream, Preventive Therapies, Suppressive Therapy, Prophylactic Vaccines (Under Development), Pain Management Medications, Analgesics, Topical Anesthetics

Which Trends Are Impacting The Progress Of The Genital Herpes Market?

Leading companies operating within the genital herpes market are increasingly engaging in strategic partnerships to enhance their technological capabilities and expand their market presence. A strategic partnership represents a collaboration where organizations combine their resources, expertise, and efforts to achieve shared objectives. For instance, in December 2024, Changchun Baike Biotechnology, a China-based biotechnology firm, and Zhuhai Livanda Biotechnology, a China-based biopharmaceutical company, together obtained approval from China’s National Medical Products Administration to begin clinical trials for LVRNA101, which is a multi-component mRNA vaccine targeting Herpes Simplex Virus Type 2 (HSV-2, genital herpes). This vaccine is engineered to induce both humoral and cellular immune responses by employing advanced mRNA technology.

Who Are The Active Companies Shaping The Genital Herpes Market?

Major companies operating in the genital herpes market are Merck & Co Inc, Abbott Laboratories, GlaxoSmithKline plc, Viatris Inc, Teva Pharmaceuticals Inc, Sandoz Inc, Valeant Pharmaceuticals International Inc, Sun Pharmaceutical Industries Ltd, Dr Reddy’s Laboratories Ltd, Apotex Inc, Zydus Group, Genocea Biosciences Inc, Glenmark Pharmaceuticals Inc, Maruho Co Ltd, Eurocine Vaccines AB, Vical Incorporated, Gilead Sciences Inc, Johnson & Johnson Inc, AstraZeneca plc, Moderna Inc, Assembly Biosciences Inc

Get The Full Genital Herpes Market Report:

https://www.thebusinessresearchcompany.com/report/genital-herpes-global-market-report

Which Region Leads The Genital Herpes Market In Overall Market Size?

North America was the largest region in the genital herpes market in 2025. The regions covered in the genital herpes market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Genital Herpes Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/genital-herpes-global-market-report

Browse Through More Reports Similar to the Global Genital Herpes Market 2026, By The Business Research Company

Herpes Simplex Virus Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/herpes-simplex-virus-treatment-global-market-report

Genital Warts Market Report 2026

https://www.thebusinessresearchcompany.com/report/genital-warts-global-market-report

Sexually Transmitted Infections Stis Market Report 2026

https://www.thebusinessresearchcompany.com/report/sexually-transmitted-infections-stis-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795